Oscar Health Sees Unusually High Options Volume (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR) was the recipient of unusually large options trading activity on Tuesday. Traders acquired 27,373 call options on the company. This is an increase of approximately 303% compared to the average volume of 6,798 call options.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective on the stock. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $21.56.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $15.90 on Wednesday. The firm’s 50-day moving average price is $14.71 and its 200-day moving average price is $16.70. Oscar Health has a 1-year low of $12.43 and a 1-year high of $23.79. The firm has a market capitalization of $3.93 billion, a P/E ratio of -794.35, a P/E/G ratio of 0.50 and a beta of 1.73. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Equities research analysts anticipate that Oscar Health will post 0.91 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Richard Scott Blackley sold 25,279 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $457,044.32. Following the sale, the chief financial officer now owns 881,841 shares of the company’s stock, valued at $15,943,685.28. The trade was a 2.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now directly owns 146,036 shares in the company, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 78,610 shares of company stock valued at $1,421,269. 25.11% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently made changes to their positions in OSCR. JPMorgan Chase & Co. raised its holdings in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. BIT Capital GmbH raised its holdings in shares of Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after acquiring an additional 4,396,872 shares during the last quarter. Deerfield Management Company L.P. Series C raised its holdings in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock worth $159,062,000 after acquiring an additional 3,983,325 shares during the last quarter. Hennessy Advisors Inc. grew its position in Oscar Health by 550.3% in the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after purchasing an additional 3,544,300 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC grew its position in Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after purchasing an additional 2,151,256 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.